A Phase 2 Trial of ALIMTA (Pemetrexed) Plus Gemcitabine in Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium

Mise à jour : Il y a 4 ans
Référence : NCT00034593

Femme et Homme

Extrait

Definition: Patients with bladder cancer will be participating in this study for the treatment of abnormal cells in the bladder that have returned after initial treatment OR have moved to a new site in the body.


Critère d'inclusion

  • Urologic Neoplasms

Liens